Protein geranylgeranyltransferase-I (PGGT-I) and protein farnesyltransferase (PFT) attach geranylgeranyl and farnesyl groups, respectively, to the C termini of eukaryotic cell proteins. In vitro, PGGT-I and PFT can transfer both geranylgeranyl and farnesyl groups from geranylgeranyl pyrophosphate (GGPP) and farnesyl pyrophosphate (FPP) to their protein or peptide prenyl acceptor substrates. In the present study it is shown that PGGT-I binds GGPP 330-fold tighter than FPP and that PFT binds FPP 15-fold tighter than GGPP. Therefore, in vivo, where both GGPP and FPP compete for the binding to prenyltransferases, PGGT-I and PFT will likely be bound predominantly to GGPP and FPP, respectively. Previous studies have shown that K-Ras4B and the Ras-related GTPase TC21 are substrates for both PGGT-I and PFT in vitro. It is shown that TC21 can compete with the C-terminal peptide of the ␥ subunit of heterotrimeric G proteins and with the C-terminal peptide of lamin B for geranylgeranylation by PGGT-I and for farnesylation by PFT, respectively. K-Ras4B competes in both cases but is almost exclusively farnesylated by PFT in the presence of the lamin B peptide competitor. Rapid and single turnover kinetic studies indicate that the rate constant for the PGGT-I-catalyzed geranylgeranyl transfer step of the reaction cycle is 14-fold larger than the steady-state turnover number, which indicates that the rate of the overall reaction is limited by a step subsequent to prenyl transfer such as release of products from the enzyme. PGGT-I-catalyzed farnesylation is 37-fold slower than geranylgeranylation and is limited by the farnesyl transfer step. These results together with earlier studies provide a paradigm for the substrate specificity of PGGT-I and PFT and provide information that is critical for the design of prenyltransferase inhibitors as anti-cancer agents.
Modification of the C termini of specific eukaryotic proteins by attachment of either 15-carbon farnesyl or 20-carbon geranylgeranyl groups is required for their proper membrane targeting and functional activation (1) (2) (3) (4) (5) (6) (7) (8) (9) . Two closely related enzymes protein farnesyltransferase (PFT) 1 and PGGT-I transfer prenyl groups from prenyl pyrophosphates to proteins that contain a C-terminal CaaX motif (C is cysteine, a is usually an aliphatic amino acid, and X is a variety of amino acids) (10 -13) . The X residue of this motif plays a major role in recognition by these two enzymes (14) . PFT preferentially transfers a farnesyl group to the cysteine residue of the CaaX motif when X is serine, methionine, glutamine, or cysteine, and possibly other residues. PGGT-I preferentially geranylgeranylates proteins having a C-terminal leucine or phenylalanine. PFT and PGGT-I consist of a common ␣ subunit and distinct ␤ subunits (15) (16) (17) (18) . A third enzyme, protein geranylgeranyltransferase-II, also known as Rab geranylgeranyltransferase, transfers the 20-carbon prenyl group to both cysteines of Rab proteins that have C-terminal sequences CXC, CC, or possibly CCXX (19, 20) . Although the C-terminal CaaX tetrapeptides are sufficient to be recognized and prenylated by PFT and PGGT-I, there appears to be additional determinants present in certain protein substrates that are important recognition features. The polylysine domain near the C terminus of K-Ras4B-CVIM and regions of ␥ subunits of heterotrimeric G proteins upstream of the CaaX sequence influence prenylation patterns in vitro and in cell lines over-expressing these proteins (21, 22) . Rab geranylgeranyltransferase does not detectably utilize short peptides as substrates but has a unique subunit called Rab escort protein that binds to Rab proteins via contacts with regions that lie far away from the C-terminal site of prenylation (23, 24) . Steady-state kinetic analyses of PFT and PGGT-I show that both enzymes can operate by a random sequential mechanism in which either prenyl donor or acceptor binds first to the enzyme followed by binding of the other substrate to form a ternary complex that goes on to products. However, operationally, both enzymes show a strong tendency to bind prenyl pyrophosphate first (25) (26) (27) (28) . Both PFT and PGGT-I have been shown to tightly bind both FPP and GGPP (12, 29, 30) . This result plus the observation that H-Ras-CVLS protein can be covalently cross-linked to the ␤ subunit of PFT suggest that the common ␣ subunit binds prenyl pyrophosphate and the distinct ␤ subunits bind prenyl acceptors (29) . However, recent studies show that photoaffinity analogs of FPP and GGPP exclusively label the ␤ subunits of PGGT-I and PFT (26, 31, 32) , and cross-linking studies with photoreactive peptide prenyl acceptors suggest that prenyl acceptors bind to an ␣ subunit/␤ subunit interface (33) .
PFT and PGGT-I show mixed specificity under certain conditions. Purified PGGT-I can transfer both geranylgeranyl and farnesyl groups to protein or peptide substrates ending with leucine and can geranylgeranylate substrates ending with serine (26, 34) . PFT can transfer a geranylgeranyl as well as a farnesyl group to substrates having a C-terminal methionine (25) . The small GTP-binding protein Rho B exists as a mixture of farnesylated and geranylgeranylated forms when produced in transfected COS cells or in a reticulocyte lysate translation mixture (35) . Rho B is a poor substrate for PFT in the presence of FPP or GGPP but can be efficiently geranylgeranylated or farnesylated by PGGT-I in the presence of GGPP or FPP, respectively (30) . Some prenyl acceptors seem to be substrates for both prenyltransferases. The oncogenic proteins K-Ras4B-CVIM and the Ras-related GTP-binding protein TC21-CVIF (also known as R-Ras2) can be farnesylated by PFT and geranylgeranylated by PGGT-I in vitro (21, 36) . Trueblood and co-workers (37) showed that over-expression of the ␤ subunit of PFT or PGGT-I in yeast can partially overcome the inactivating effect of mutation in the ␤ subunit of the other enzyme (PGGT-I or PFT, respectively). This suggests that under forcing conditions, both PFT and PGGT-I can prenylate proteins that are normally prenylated by a single prenyltransferase.
In this paper we report studies aimed at understanding the specificities of PFT and PGGT-I in detail with particular focus on determining the precise affinities of PFT and PGGT-I for both FPP and GGPP. These results, when combined with our earlier studies (26) , provide a comprehensive description of the features of these enzymes that dictate their specificities. The results are important for predicting the consequences of inhibiting PFT or PGGT-I on protein prenylation in cells. This is of considerable interest because inhibitors of these enzymes are being developed as potential anti-cancer drugs due to their ability to block prenylation and thus transforming activity of oncogenic RAS proteins (38, 39) . We also report kinetic studies of PGGT-I which probe the nature of the rate-limiting step for the prenyl transfer reactions, and our results are compared with the analogous study carried out with PFT (40) .
EXPERIMENTAL PROCEDURES
Materials-Biotin-␥ 6 -CAIL and biotin-lamin B-CAIS were synthesized and analyzed by mass spectroscopy as described previously (34) . H]GGPP (15 Ci/mmol, labeled on carbon-1) and unlabeled FPP and GGPP were purchased from American Radiolabeled Chemicals. The chemical and radiometric purities of these prenyl pyrophosphates were routinely monitored by thin layer chromatographic analysis as described (34) , and compounds were not used if either purity was less than 90%. Recombinant baculoviruses that express the ␣ and ␤ subunits of rat PFT (Professor Y. Reiss, Tel-Aviv University) and that express the ␤ subunit of rat PGGT-I (Professor J. L. Goldstein, Southwestern Medical Center) were obtained as gifts from the indicated individuals. RhoB-CKVL was obtained as a generous gift from Professor J. L. Goldstein. H-Ras-CVLS produced in Escherichia coli was prepared as described (41) . K-Ras4B-CVIM was obtained from the cytosol of baculovirus-infected Sf9 cells as described (42) . TC21-CVIF was obtained as a generous gift from Dr. V. Manne (Bristol-Myers Squibb, Princeton, NJ).
Production and Purification of Recombinant Rat PGGT-I and PFTSf9 cells were cultured in IPL-41 medium supplemented with 10% fetal bovine serum, 4 mg/ml yeastolate, 0.1% Pluronic F-68, and 50 g/ml gentamycin (all from Life Technologies, Inc.). A 6-liter culture of Sf9 cells (log phase, about 1.5 ϫ 10 6 cells/ml) was coinfected with recombinant viruses expressing the ␣ subunit of PFT/PGGT-I and either the ␤ subunit of PGGT-I or the ␤ subunit of PFT at multiplicities of infection of 1. All subsequent steps were carried out at 4°C unless otherwise noted. For PGGT-I production, the cells were harvested 72 h after infection by centrifugation and washed once with 20 mM Tris-HCl, 1 mM DTT, 0.13 M NaCl, pH 8.0. The cell pellet was frozen at Ϫ80°C. The frozen cells were thawed on ice in 300 ml of 20 mM Tris-HCl, 1 mM DTT, and 0.05 M NaCl, pH 8.0 (buffer A) containing freshly added protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 30 M tosyl-lysinechloromethyl ketone, 30 M tosyl-phenylalanine-chloromethyl ketone, and 10 g/ml each of aprotinin, leupeptin, and pepstatin A, all from Sigma). The cells were disrupted by six strokes in a Dounce homogenizer. The lysate was centrifuged for 10 min at 10,000 ϫ g, and the supernatant was centrifuged for 1 h at 100,000 ϫ g. The resulting supernatant was fractionated on a column (2.6 ϫ 20 cm) of Q-Sepharose (Pharmacia Biotech Inc.) equilibrated in buffer A as described previously (12) . A linear gradient (4-liter total volume) of NaCl concentrations from 0.05 to 0.6 M was applied, and PGGT-I was eluted at about 0.3 M NaCl. The enzyme peak fractions (assayed with 5 M biotin-␥ 6 -CAIL and 1 M [ 3 H]GGPP as described below) were combined, dialyzed against buffer A, and then chromatographed on a Mono-Q HR10/10 column (Pharmacia) as described previously (12) . The yield of PGGT-I is 90 mg, and the purity was more than 90% as judged by SDS-polyacrylamide gel electrophoresis. The specific activity is 4.7 microunits/g, where 1 microunit is the amount of enzyme that produces 1 pmol of product per min at 30°C using 2 M [ 3 H]GGPP and 5 M biotin-␥ 6 -CAIL peptide as substrates. PGGT-I was stored at Ϫ80°C.
For purification of PFT, infected Sf9 cells (3.6-liter culture) were harvested 2-3 days after infection by centrifugation, and all subsequent steps were carried out at 4°C. The cells were washed twice with phosphate-buffered saline, and the cell pellet was taken up in 300 ml of 20 mM Tris-HCl, 50 mM MgCl 2 , 20 M ZnCl 2 , 1 mM DTT, pH 7.4. The cell suspension was transferred to a pre-chilled cavitation bomb (in three 100-ml portions); the bomb was charged with N 2 to 600 p.s.i., and after 30 min, the sample was drained from the bomb through a high pressure outlet valve. The cell lysate was centrifuged at 100,000 ϫ g for 45 min. To the supernatant was added solid ammonium sulfate to give 55% saturation, and the suspension was centrifuged at 18,000 ϫ g for 20 min. The protein pellet was taken up in 31 ml of buffer B (20 mM Tris-HCl, 50 mM NaCl, 20 M ZnCl 2 , 1 mM DTT, pH 7.5), and the sample was dialyzed twice against 2 liters of buffer B. The sample was centrifuged at 18,000 ϫ g for 20 min, filtered through a 0.22-m filter cartridge, and loaded onto a Mono-Q HR10/10 column. The column was washed with 15 ml of buffer B and then developed with a linear gradient of 0.05-1 M NaCl in buffer B (100 ml total). PFT (assayed as described below) elutes at about 0.5 M NaCl and was stored at Ϫ80°C. The specific activity of the final PFT preparation is 138 microunits/g based on the assay with 10 M H-Ras-CVLS and 2 3 H]FPP of known specific radioactivity. The absolute mole amount of PGGT-I was determined from the absorbance at 280 nm using the extinction coefficient of 134 mM Ϫ1 cm Ϫ1 , which was calculated from the amino acid sequence using the published formula (44) .
PGGT-I and PFT Assays-To assay the geranylgeranylation activity of PGGT-I, 1 M [ 3 H]GGPP (15 Ci/mmol) and 5 M biotin-␥ 6 -CAIL were incubated with 0.1 g of rat PGGT-I in a total volume of 20 l containing 30 mM potassium phosphate, 5 mM DTT, 0.5 mM MgCl 2 , 20 M ZnCl 2 , pH 7.7. After 5 min at 30°C, the reaction was terminated by boiling for 3 min, and 40 l of avidin-agarose suspension (50% aqueous suspension, Pierce) was added to the mixture to measure radioactivity transferred to the biotinylated peptide as described previously (12) . For assaying the farnesylation activity of PGGT-I, 1 M Mixtures were incubated at 30°C for 10 min and terminated by the addition of 200 l of 10% HCl in ethanol. The amount of radiolabeled farnesylated H-Ras-CVLS was quantified using the glass fiber filter binding method (25 4 HCO 3 (prenyl pyrophosphate stock solution solvent) in a total volume of 50 l. The mixture was incubated at 30°C for 15 min and applied to a 0.5 ml-column of Sephadex G-50 preequilibrated with 30 mM potassium phosphate, 1 mM DTT, 0.1% noctylglucoside, pH 7.7. The column was spun for 2 min at 2,500 rpm in an HB-4 swinging-bucket rotor and then washed once with 50 l of the same buffer by spinning in the same way. These two eluants that contain protein but negligible amounts of unbound prenyl pyrophosphate were combined, and the mixture was submitted to scintillation counting. Control experiments without enzyme were also carried out for each assay, and the amount of cpm eluted in the first two eluants was typically 10 -50 cpm, and this value was subtracted from that measured in the presence of enzyme.
Rapid Quench Kinetic Analysis-Pre-steady-state kinetic measurements were made using a KinTek Quench Flow apparatus Model RQF-3. Three syringes were driven by a step motor. PGGT-I or PFT alone or together with Binding of the radioactive, prenylated and biotinylated peptide to streptavidin on the the beads places the radioactive prenyl group in close proximity to the scintillant bead. Each set of data obtained was well fit to the first-order equation, and the reaction rate constants were calculated based on the first-order equation. Additional details are given in Table II Table III ), 2 M peptide substrate (see Table III ) in 30 l of 30 mM potassium phosphate, 5 mM DTT, 0.5 mM MgCl 2 , 20 M ZnCl 2 , pH 7.7. After 15 min at 30°C, a 10-l aliquot was quenched with 2 ϫ Laemmli loading buffer. After boiling, the sample was analyzed by SDS-polyacrylamide gel electrophoresis (12.5% gel). The gel was prepared for fluorography, and the radiolabeled bands were visualized using x-ray film (26) . Gel slices containing radiolabeled proteins were solubilized in 0.5 ml of 30% H 2 O 2 at 60°C overnight, and the samples were submitted to scintillation counting. The cpm data were converted to pmol of prenylated protein by correcting for quenching. This was carried out by mixing a known amount of [ 3 H]GGPP with a blank gel slice and determining the cpm as described above. To quantify the amount of prenylated peptide, a 10-l aliquot of the same prenylation reaction mixture was mixed with 200 l of methanol; the sample was applied to a disposable anion exchange column (SpeNϩ, 1 ml bed, Baker) to remove [ 3 H]prenyl pyrophosphate, and the column was washed with five 200-l portions of methanol. The eluant was collected in a single fraction, and solvent was removed in a Speed-vac concentrator (Savant Instruments). The residue was taken up in methanol and spotted onto a 20 ϫ 20-cm plate of silica gel 60 (EM Science). The plate was developed with n-propanol:concentrated NH 4 OH:water (6:3:1 by volume) and sprayed with EN 3 HANCE (DuPont NEN) prior to exposure to x-ray film. The region of the plate that contained the radioactive prenylated peptide was scraped, and the silica was submitted to scintillation counting. Counting efficiency was determined by counting a known amount of [ 3 H]GGPP together with blank silica gel.
RESULTS

Differential Binding of GGPP and FPP to PGGT-I and PFT-
We have previously shown with in vitro reactions that purified bovine PGGT-I is able to transfer both geranylgeranyl and farnesyl groups to substrates containing C-terminal CaaL motifs such as biotin-␥ 6 -CAIL (26, 34) . Steady-state kinetic studies of PGGT-I showed that the K M values for the interaction of GGPP and FPP with PGGT-I in the presence of a saturating amount of biotin-␥ 6 -CAIL are similar (0.6 M) (26) . In the presence of saturating amounts of biotin-␥ 6 -CAIL and prenyl donor, k cat for geranylgeranylation and farnesylation are similar (26) . Nevertheless, addition of 1 M nonradiolabeled GGPP to PGGT-I reaction mixtures containing 1 M [ 3 H]FPP and 2 M biotin-␥ 6 -CAIL nearly abolished the transfer of the radiolabeled farnesyl group to peptide (Table I and Ref. 34 ). In addition, in PGGT-I reaction mixtures containing equimolar amounts of FPP and [
3 H]GGPP, the amount of radioactive geranylgeranylated peptide formed was the same as in reaction mixtures that did not contain FPP (Table I and Ref. 34 ). This suggests that PGGT-I has different affinities for GGPP and FPP. Fig.  1A is saturated. After spin column gel filtration, 37 Ϯ 3% (2,900 cpm) of the bound cpm was transferred to biotin-␥ 6 -CAIL after incubation periods of 10, 30, and 180 s. Again, the cpm transferred to peptide was not reduced if 4 M unlabeled GGPP was added along with peptide.
It was initially thought that the lower affinity binding of [ 3 H]GGPP to PGGT-I (Fig. 1A) is due to nonspecific interaction of this isoprenoid with the enzyme. However, this is not the case. If it were, 1,100 cpm would be transferred to peptide in the presence of excess unlabeled GGPP, i.e. the same amount of radioactivity that is transferred from the high affinity PGGT- As shown in Fig. 1A , PGGT-I that had been incubated with 5 mM DTT for 30 min at 30°C at neutral pH leads to a form of the enzyme that only shows that high [ 3 H]GGPP binding component and up to 56 fmol of [ 3 H]GGPP can be bound. This suggests that two forms of PGGT-I exist that differ in their patterns of disulfides; the ␤-chain of PPGT-I contains 15 cysteines throughout its length (16) . As will be shown by single turnover kinetic studies presented below, the rate of transfer of the geranylgeranyl group from GGPP to peptide acceptor catalyzed by these two forms of PGGT-I are the same within experimental error.
As shown in Fig. 1A 3 H]GGPP was the same for both incubation periods (data not shown). Thus, the 60-min incubation period used in the experiments shown in Fig. 3A is sufficient to attain equilibrium. At equilibrium, the ratio of binary complexes is given by Equation 1.
This ratio is unity when [FPP] is 5 M and [ 3 H]GGPP is 20 nM (Fig. 3A) , and thus
, which is in close agreement with the results of the direct binding titrations (Fig.  1). Fig. 3B shows the analogous experiment done with PFT, 
GGPP / K d
FPP ratio is 9, which agrees reasonably well with the 15-fold difference in dissociation constants obtained from the direct binding studies (Fig. 2) .
Single Turnover Rates of PGGT-I-catalyzed Geranylgeranylation and Farnesylation-Rapid quench experiments were carried out to measure the rate of transfer of the geranylgeranyl or farnesyl group to biotin-␥ 6 -CAIL catalyzed by PGGT-I, and results are summarized in Table II (Fig. 4B, Table II ), which is 37-fold smaller than the rate constant for geranylgeranyl transfer. In these experiments, higher concentrations of reactants were used since [ 3 H]FPP binds about 330-fold weaker to PGGT-I than does [ 3 H]GGPP. In addition, 10 M unlabeled GGPP was included so that single turnover from the PGGT-I⅐[ 3 H]FPP⅐biotin-␥ 6 -CAIL complex is being measured owing to the fact that once [
3 H]FPP dissociates from the enzyme, it will be irreversibly replaced by GGPP.
Rapid quench experiments were also performed with PFT acting on biotin-TKCVIM. A solution of PFT (150 nM) and [ , respectively). The rate constant for farnesyl transfer is similar to the value of 0.44 s Ϫ1 previously reported for PFT-catalyzed farnesylation of biotin-GLPCVVM (40) .
Prenyl Acceptor Specificity Studies-In vitro prenylation studies with the prenyl acceptors K-Ras4B-CVIM, RhoB-CKVL, and TC21-CVIF have shown that these proteins can be farnesylated or geranylgeranylated (21, 30, 35, 36) , and these reactions were studied in more detail in the present study. The relative affinities of PGGT-I and PFT for GGPP and FPP described above are preserved in the presence of these protein substrates. This is shown in Table I (Table I) .
Competition between prenyl acceptors for geranylgeranylation by PGGT-I⅐[ 3 H]GGPP and for farnesylation by PFT⅐[ 3 H]FPP was also studied, and the results are summarized in Table III . DISCUSSION The results in this study clearly show that both PGGT-I and PFT display binding selectivity for their respective prenyl pyrophosphate substrates. The 330-fold higher affinity of GGPP versus FPP for PGGT-I does not contradict the published data showing that micromolar amounts of PGGT-I are capable of binding both GGPP and FPP (30) (also confirmed in our lab). Since the K d values for the complexes of PGGT-I with GGPP and FPP are 3 nM and 1 M, respectively, micromolar amounts of enzyme can be titrated with micromolar amounts of GGPP or FPP. It is only when the concentration of PGGT-I is near the K d ϭ 3 nM for GGPP, as is the case in the present study, that the very high affinity of PGGT-I for GGPP can be detected. The same applies to PFT (29) , and in the present study using low concentrations of PFT it is found that FPP binds about 15-fold tighter to PFT than does GGPP. (10 M) , and at the indicated times, the reaction was quenched, and the amount of radiolabeled farnesylated peptide was determined as described under "Experimental Procedures."
As shown previously, values of k cat are similar for PGGT-Icatalyzed geranylgeranylation and farnesylation of biotin-␥ 6 -CAIL under conditions where both prenyl donor and acceptor are saturating (26) . However, this in vitro situation is not relevant to the situation that exists inside the cell where both GGPP and FPP are present and compete for binding to PGGT-I. Under competitive conditions, geranylgeranylation is greatly preferred over farnesylation unless the concentration of FPP in the cell is more than 330-fold higher than the concentration of GGPP, which seems unlikely. Even if there is a small amount of PGGT-I⅐FPP in the cell, the K M for the interaction of this binary complex with biotin-␥ 6 -CAIL is 29-fold higher than the K M for the interaction of PGGT-I⅐GGPP with the same peptide (26) , and this would disfavor the farnesylation reaction. In the presence of saturating biotin-␥ 6 -CAIL, values of K M for FPP and GGPP are similar (26) . However, this situation is also not relevant to the reaction in the cell or in vitro since although prenyl acceptor can bind before prenyl donor, the PGGT-Icatalyzed reaction cycle involves the preferential binding of GGPP prior to prenyl acceptor (26) . The same is true for PFT, which preferentially binds FPP before prenyl acceptor (25) , and binds FPP 15-fold tighter than GGPP. Since the selectivity of PFT for binding FPP versus GGPP is not so rigid, it is difficult at this point to say with confidence that PFT will be loaded only with FPP in vivo, especially since the relative sizes of the FPP and GGPP in vivo pools are not known.
For the reasons given above, it seems likely that in the cell PFT and PGGT-I are fully loaded with their respective prenyl pyrophosphate, and one may now ask which prenyl acceptors do these binary complexes choose. Such a selection is dictated by steady-state Equation 2.
Equation 2 relates the ratio of velocities, ( PA1 )/( PA2 ), for prenylation of two competing prenyl acceptors, PA1 and PA2, respectively, to the ratio of concentrations of the prenyl acceptors and the ratio of k cat /K M values for PA1 and PA2. Equation 2 applies to both the PGGT-I⅐GGPP and PFT⅐FPP complexes. In this equation, k cat is the turnover number under conditions in which both prenyl donor and prenyl acceptor are saturating, and K M is the Michaelis constant for the interaction of the prenyl acceptor with the prenyltransferase⅐prenyl pyrophosphate binary complex. In the case of PGGT-I-catalyzed geranylgeranylation of biotin-␥ 6 -CAIL, which has a C-terminal leucine, versus the biotin-␥ 6 -CAIL analog in which the C-terminal leucine is changed to serine, the former is calculated to be preferentially geranylgeranylated by 121-fold using the published kinetic data (26) . This preference is due to a 10-fold larger k cat and a 12-fold lower K M for the reaction of the peptide ending in leucine versus the one ending in serine, and thus there is k cat and K M selectivity for the geranylgeranyl acceptor. Kinetic data for PFT-catalyzed farnesylation of Ras-CVIM (farnesyl acceptor) and Ras-CAIL (geranylgeranyl acceptor) are available (25) . According to Equation 2 and the published data, the PFT⅐FPP complex prefers Ras-CVIM over Ras-CAIL by a factor of 40 (relative k cat /K M values). Interestingly, the k cat for farnesylation of Ras-CVIM is 2.5-fold smaller than the k cat for farnesylation of Ras-CAIL. However, the 80-fold lower K M for Ras-CVIM compared with Ras-CAIL more than offsets the difference in k cat values, and thus Ras-CVIM is the preferred substrate based on K M selectivity. These specificity features of PGGT-I and PFT are summarized in Fig. 5 .
As described in the Introduction, the GTPases RhoB-CKVL, TC21-CVIF, and K-Ras4B-CVIM, which are members of the Ras superfamily of proteins, have been reported to undergo both farnesylation and geranylgeranylation. The presence of these proteins in reaction mixtures did not influence the preference of PFT and PGGT-I in binding FPP and GGPP, respectively (Table I) . Thus, the prenylation selectivity of these proteins will be dictated by their k cat /K M values in comparison to those of other prenyltransferase substrates present in the cell according to Equation 2. When K-Ras4B-CVIM competes against an equal concentration of biotin-␥ 6 -CAIL (the ␥ 6 protein is known to be geranylgeranylated in vivo (45) ) for geranylgeranylation by PGGT-I⅐GGPP, the peptide is preferred by 8.7-fold. Competition between K-Ras4B-CVIM and biotinlamin B-CAIS (the lamin B protein is known to be farnesylated in vivo (46) ), for farnesylation by PFT-I⅐FPP leads to almost exclusive farnesylation of the Ras protein. These results are consistent with those of James et al. (21) who showed that the K M for the interaction of K-Ras4B-CVIM with PFT⅐FPP is about 10-fold smaller than the K M for the interaction of the same protein with PGGT-I⅐GGPP; the k cat for these two reactions are similar. These results give only the relative velocities for the pair of prenyl acceptors studied. In the cell K-Ras4B-CVIM is competing with many other substrates, and the relative k cat /K M values for these other substrates are not known. Nevertheless, the results suggest that K-Ras4B-CVIM will nor- mally become farnesylated in cells, but if a PFT-selective inhibitor is used, K-Ras4B-CVIM can effectively compete with geranylgeranyl acceptors for geranylgeranylation by PGGT-I. This point has obviously important consequences for the design of prenyltransferase inhibitors as anti-cancer drugs. Indeed, James et al. (47) showed that a PFT-selective inhibitor does block Ras-dependent activation of the mitogen-activated protein kinase cascade when the cell is activated by oncogenic H-Ras. In contrast, when this cascade is regulated by endogenous Ras, the PFT inhibitor has no effect. K-Ras4B-CVIM may be the endogenous activator of mitogen-activated protein kinase in the cells studied, and inhibition of PFT may cause K-Ras4B-CVIM to become geranylgeranylated by PGGT-I with restoration of its signaling function (47). TC21-CVIF, which is a Ras-related protein with oncogenic potential, has been shown in vitro to be farnesylated by PFT and geranylgeranylated by PGGT-I (36) . In the present study, it is shown that TC21-CVIF can be a substrate for PGGT-I and PFT because it competes as well with biotin-␥ 6 -CAIL for geranylgeranylation by PGGT-I as it does with lamin B for farnesylation by PFT (Table III) , although the peptide substrates are 10-fold preferred in both cases. The CaaX sequence of TC21 is unusual in that it has a C-terminal phenylalanine. However, this is probably not the reason that TC21 is a substrate for both PGGT-I and PFT because another GTPase CDC42, which also has a C-terminal phenylalanine, is a much better substrate for PGGT-I than for PFT (34) . Interestingly, the transformation of cells by oncogenic TC21-CVIF is not inhibited by a selective PFT inhibitor, and the present results support the suggestion of Carboni and co-workers (36) that TC21-CVIF may be geranylgeranylated in cells treated with PFT inhibitors. The type of prenyl group attached to TC21-CVIF in cells treated or not treated with prenyltransferase inhibitors remains to be determined.
Furfine and co-workers (40) measured the single turnover rate of conversion of the PFT⅐FPP⅐peptide-CVVM complex to products and obtained a value of 0.06 s
Ϫ1
. Interestingly, this value is 7.3-fold smaller than the k cat for the steady-state reaction when both prenyl donor and acceptor are saturating. This implies that a step after the conversion of the ternary complex to the enzyme product complex is rate-determining for steady-state turnover. The slow step may be release of prenylated peptide from the enzyme (40) . The same appears to be true for the PGGT-I⅐GGPP⅐biotin-␥ 6 -CAIL complex, which undergoes conversion to product with a single turnover rate constant of 0.56 s Ϫ1 under conditions where binding of GGPP or peptide to the enzyme is not rate-determining (Table II) . With the same preparation of PGGT-I, the k cat for steady-state turnover in the presence of saturating amounts of both biotin-␥ 6 -CAIL and GGPP is 0.032 s Ϫ1 . Thus the single turnover geranylgeranyl transfer rate constant is 14-fold faster than the steady-state turnover number, which establishes that a step after prenyl transfer, such as product release, is rate-determining. The conversion of PGGT-I⅐FPP⅐biotin-␥ 6 -CAIL to products occurs with a 37-fold smaller rate constant (0.015 s Ϫ1 ) than the analogous geranylgeranylation reaction, and this value is similar to the steady-state k cat of 0.012 s Ϫ1 measured with saturating amounts of FPP and biotin-␥ 6 -CAIS. Thus, the rate of PGGT-I-catalyzed farnesylation is probably limited by the chemical step of prenyl transfer. Thus, the similar observed values of k cat for PGGT-catalyzed geranylgeranylation and farnesylation (26) is not due to similar rate constants for the prenyl transfer step.
The biphasic binding of [ 3 H]GGPP to PGGT-I purified in the presence of 1 mM DTT (Fig. 1A) was unexpected. The weaker binding component is not due to nonspecific adsorption of 3 H]GGPP bound in this weaker complex is transferred to peptide without exchange with free GGPP in the buffer. Since the PGGT-I used in this study is recombinant and originates from plaque-purified baculoviruses expressing the ␣ and ␤ subunits of this enzyme, the low and high affinity binding of [
